See also this year's filing and all EDGAR filings for this company.
PDF Report 0001087294_2013_Cumberland_Pharmaceuticals_INC.pdf
Logs
Graph
Absolute values for 0001087294, Cumberland Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 87,232,242 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 9,476,798 |
| 2 | PropertyPlantAndEquipmentNet | 1,188,914 |
| 3 | remainder_Assets | 695,777 |
| 4 | LiabilitiesCurrent | 8,055,360 |
| 5 | LiabilitiesNoncurrent | 611,933 |
| 6 | remainder_Liabilities | 4,359,951 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 9,096,165 |
| 9 | ResearchAndDevelopmentExpense | 5,095,172 |
| 10 | remainder_Expenses | 29,158,559 |
| 11 | remainder_Revenues | 48,851,237 |
| 12 | remainder_NetIncome | 304,865 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 98,593,731 |
| 1 | Liabilities | 13,027,244 |
| 2 | Expenses | 43,349,896 |
| 3 | Revenues | 48,851,237 |
| 4 | StockholdersEquity | 85,566,487 |
| 5 | NetIncome | 5,806,206 |
| 6 | ComprehensiveNetIncome | 5,806,206 |
| 7 | BaseVar | 102,063,486 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.45 |
| 9 | EconomicCapitalRatio | 3.99 |
Edgar->Model Mapping
Feature Distribution
Change over Time
